No profile data available.
Hyperion DeFi, Inc. (HYPD) is a healthcare company in the eye treatment pharmaceuticals industry, based in Dallas, United States, with about 9 full-time employees.
It reported revenue of $57,336 for fiscal year 2024, up 1414.0% from fiscal year 2023, and net income of -$49.82 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $302,506, up 18515.8% from a year before. Its market capitalization was $51.69 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem.
Hyperion DeFi reported $57,336 in revenue for fiscal year 2024, up 1414.0% from $3,787 in fiscal year 2023. In Q3 2025 revenue was $302,506.
$51.69 million as of October 9, 2026.
Listed companies of a similar size in the same industry (eye treatment pharmaceuticals) include Lenz Therapeutics, Inc. (LENZ), Okyo Pharma Limited (OKYO), Aldeyra Therapeutics, Inc. (ALDX), Kiora Pharmaceuticals, Inc. (KPRX).